Cargando…

Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis

PURPOSE: The topical nonsteroidal anti-inflammatory drug bromfenac 0.09% has a potential benefit in uveitic macular edema (UME) with a safe side effect profile. The aim of the study is to assess the efficacy of bromfenac sodium solution in the treatment of UME. METHODS: The charts of 10 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saade, Joanna S., Istambouli, Rachid, AbdulAal, Marwan, Antonios, Rafic, Hamam, Rola N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547661/ https://www.ncbi.nlm.nih.gov/pubmed/34759667 http://dx.doi.org/10.4103/meajo.meajo_134_21

Ejemplares similares

Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
por: Palacio, Claudia, et al.
Publicado: (2016)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
por: Cable, Melissa
Publicado: (2012)

Uveitis in the Aging Eye: Incidence, Patterns, and Differential Diagnosis
por: Abdulaal, Marwan R., et al.
Publicado: (2015)

Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis
por: Hanif, Junaid, et al.
Publicado: (2021)

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
por: Wang, Xiao Jing, et al.
Publicado: (2011)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation
por: Chávez-Mondragón, Eduardo, et al.
Publicado: (2019)

Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
por: Song, Seok Hyeon, et al.
Publicado: (2020)

Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography
por: Albano, Valeria, et al.
Publicado: (2022)

Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018)

Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021)

Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
por: Sheppard, John D
Publicado: (2016)

Frequency and Treatment Regimens of Macular Edema in 1946 Consecutive Patients with Noninfectious Uveitis at a Tertiary Ophthalmic Center in Shaanxi, China
por: Xue, Yan-Qi, et al.
Publicado: (2023)

Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013)

Targeting interleukin-6 for noninfectious uveitis
por: Lin, Phoebe
Publicado: (2015)

Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)

KMg(0.09)Fe(1.91)(PO(4))(2)
por: Yatskin, Michael M., et al.
Publicado: (2012)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

Clinical Outcomes of Cyclosporine Treatment for Noninfectious Uveitis
por: Lee, Sun Ho, et al.
Publicado: (2012)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)

Noninfectious Uveitis in Rheumatology: Patterns, Treatment, and Outcomes
por: Younus, Raheel, et al.
Publicado: (2023)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Chronic Postoperative Endophthalmitis: A Review of Clinical Characteristics, Microbiology, Treatment Strategies, and Outcomes
por: Maalouf, Fadi, et al.
Publicado: (2012)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
por: Palla, Swetha, et al.
Publicado: (2015)

Noninfectious uveitis: strategies to optimize treatment compliance and adherence
por: Dolz-Marco, Rosa, et al.
Publicado: (2015)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Tubulointerstitial nephritis and uveitis syndrome with concurrent macular edema caused by granulomatous uveitis
por: Nishi, Tomomi, et al.
Publicado: (2020)

Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
por: Roesel, Martin, et al.
Publicado: (2011)

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
por: Pasadhika, Sirichai, et al.
Publicado: (2014)

Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
por: Maya, Jose R., et al.
Publicado: (2014)

A review and update on orphan drugs for the treatment of noninfectious uveitis
por: You, Caiyun, et al.
Publicado: (2017)

Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review
por: Norcia, Luiz Fernando, et al.
Publicado: (2021)

Case Report: A Promising Treatment Strategy for Noninfectious Uveitis
por: Liu, Xiao-Bao, et al.
Publicado: (2022)

Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve
por: Kessler, Lucy Joanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3an19c0rgr0qio0v1tq15schi4